| ปี พ.ศ. 2557 |
| 1 |
การวิจัยพหุสถาบันโดยวิธีสุ่มเพื่อเปรียบเทียบประสิทธิภาพและความปลอดภัยของการรักษาด้วยยาต้านไวรัสโลพินาเวียร์/ริโทนาเวียร์ ในขนาดต่ำเทียบกับในขนาดมาตรฐานในเด็กไทยที่ติดเชื้อเอชไอวีซึ่งได้รับยาต้าน |
| ปี พ.ศ. 2555 |
| 2 |
Poor quality of life among untreated Thai and Cambodian children without severe HIV symptoms |
| 3 |
The 15th Bangkok international symposium on HIV medicine |
| 4 |
Nephelometry determined serum immunoglobulin isotypes in healthy Thai children aged 2-15 years |
| 5 |
A comparison of 3 regimens to prevent nevirapine resistance mutations in HIV-infected pregnant women receiving a single intrapartum dose of nevirapine |
| 6 |
Low dose lopinavir/ritonavir tablet achieves adequate pharmacokinetic parameters in HIV-infected Thai adolescents |
| 7 |
Causes of first hospitalization among 1121 HIV-infected children: Comparison of the pre-Pneumocystis jiroveci pneumonia prophylaxis, pre-antiretroviral therapy and antiretroviral therapy periods |
| 8 |
Recovery from lipodystrophy in HIV-infected children after substitution of stavudine with zidovudine in a non-nucleoside reverse transcriptase inhibitor-based antiretroviral therapy |
| 9 |
Prevalence of HLA-B*5701 among HIV-infected children in Thailand and Cambodia: Implications for abacavir use |
| 10 |
HIV and hepatitis B coinfection among perinatally HIV-infected thai adolescents |
| 11 |
Correlation of selenium and zinc levels to antiretroviral treatment outcomes in Thai HIV-infected children without severe HIV symptoms |
| 12 |
High virologic response rate after second-line boosted protease inhibitor-based antiretroviral therapy regimens in children from a resource limited setting |
| 13 |
Long-term lopinavir/ritonavir monotherapy in HIV-infected children |
| 14 |
Association of APOBEC3G genotypes and CD4 decline in Thai and Cambodian HIV-infected children with moderate immune deficiency |
| 15 |
Prevalence of selenium deficiency in Thai HIV-infected children without severe HIV symptoms |
| 16 |
Prevalence and risk factors of low bone mineral density among perinatally HIV-infected thai adolescents receiving antiretroviral therapy |
| 17 |
Early versus deferred antiretroviral therapy for children older than 1 year infected with HIV (PREDICT): A multicentre, randomised, open-label trial |
| 18 |
Prevalence of anemia and underlying iron status in naive antiretroviral therapy HIV-infected children with moderate immune suppression |
| 19 |
Cognitive function and neurodevelopmental outcomes in HIV-infected children older than 1 year of age randomized to early versus deferred antiretroviral therapy: The PREDICT neurodevelopmental study |
| 20 |
Pharmacokinetics of darunavir/ritonavir in Asian HIV-1-infected children aged ?7 years |
| ปี พ.ศ. 2554 |
| 21 |
Survival of HIV-infected children: A cohort study from the Asia-Pacific region |
| 22 |
The 14th Bangkok international symposium on HIV medicine |
| 23 |
The immunogenicity and safety of live attenuated varicella-zoster virus vaccine in human immunodeficiency virusinfected children |
| 24 |
Cohort profile: The TREAT Asia pediatric HIV observational database |
| 25 |
Monoboosted lopinavir/ritonavir as simplified second-line maintenance therapy in virologically suppressed children |
| 26 |
Economic evaluation of monitoring virologic responses to antiretroviral therapy in HIV-infected children in resource-limited settings |
| 27 |
Randomized study of intradermal compared to intramuscular hepatitis B vaccination in HIV-infected children without severe immunosuppression |
| 28 |
Second-line Antiretroviral therapy for HIV-infected children in resource limited settings |
| 29 |
The immunogenicity and safety of pneumococcal conjugate vaccine in human immunodeficiency virus-infected Thai children |
| 30 |
Immunologic and virologic failure after first-line NNRTI-based antiretroviral therapy in Thai HIV-infected children |
| 31 |
High prevalence of lipid abnormalities among antiretroviral-naive HIV-infected Asian children with mild-to-moderate immunosuppression |
| ปี พ.ศ. 2553 |
| 32 |
Therapeutic drug monitoring of lopinavir in human immunodeficiency virus-infected children receiving adult tablets |
| 33 |
Antiretroviral treatment outcome following genotyping in Thai children who failed dual nucleoside reverse transcriptase inhibitors |
| 34 |
The 13th Bangkok international symposium on HIV medicine |
| 35 |
Pharmacokinetics and 48 week efficacy of low-dose lopinavir/ritonavir in HIV-infected children-authors' response |
| 36 |
Thai national guidelines for the use of antiretroviral therapy in pediatric HIV infection in 2010 |
| 37 |
A 3-year follow-up of antibody response in HIV-infected children with immune recovery vaccinated with inactivated Japanese encephalitis vaccine |
| 38 |
Persistence of measles, mumps, and rubella protective antibodies 3 years after revaccination in HIV-infected children receiving antiretroviral therapy |
| 39 |
CD4 cell count criteria to determine when to initiate antiretroviral therapy in human immunodeficiency virus-infected children |
| 40 |
HIV-1 drug resistance mutations in children after failure of first-line nonnucleoside reverse transcriptase inhibitor-based antiretroviral therapy |
| 41 |
Antiretroviral therapy outcomes of HIV-infected children in the TREAT Asia pediatric HIV observational database |
| 42 |
Corrigendum to "Antibody response to hepatitis B virus re-vaccination in HIV-infected children with immune recovery on highly active antiretroviral therapy" [Vaccine 2007;25:5324-9] |
| 43 |
Characteristics of lymphocyte subsets in HIV-infected, long-term nonprogressor, and healthy Asian children through 12 years of age |
| 44 |
Poor cognitive functioning of school-aged children in thailand with perinatally acquired HIV infection taking antiretroviral therapy |
| 45 |
Measles outbreak in an orphanage: HIV-Infected children on antiretroviral therapy are still at risk |
| 46 |
Early versus deferred antiretroviral therapy in children in low-income and middle-income countries |
| ปี พ.ศ. 2552 |
| 47 |
Henoch-Sch?nlein purpura and thrombocytopenia after planned antiretroviral treatment interruption in a Thai girl with HIV infection |
| 48 |
Efficacy of non-nucleoside reverse transcriptase inhibitor-based highly active antiretroviral therapy in thai hiv-infected children aged two years or less |
| 49 |
The effectiveness of highly active antiretroviral therapy among HIV-infected children in Asian countries |
| 50 |
Early postpartum pharmacokinetics of lopinavir initiated intrapartum in Thai women |
| 51 |
Plasma efavirenz concentrations and the association with CYP2B6-516G>T polymorphism in HIV-infected Thai Children |
| 52 |
Safety and efficacy of a double-boosted protease inhibitor combination, saquinavir and lopinavir/ritonavir, in pretreated children at 96 weeks |
| 53 |
Pattern and predictors of immunologic recovery in human immunodeficiency virus-infected children receiving non-nucleoside reverse transcriptase inhibitor-based highly active antiretroviral therapy |
| 54 |
Predictors of virologic failure and genotypic resistance mutation patterns in thai children receiving non-nucleoside reverse transcriptase inhibitor-based antiretroviral Therapy |
| 55 |
Low prevalence of insulin resistance among HIV-infected children receiving nonnucleoside reverse transcriptase inhibitor-based highly active antiretroviral therapy in Thailand |
| 56 |
Reversal of growth failure in HIV-infected Thai children treated with non-nucleoside reverse transcriptase inhibitor-based antiretroviral therapy |
| 57 |
Pharmacokinetics and 48 week efficacy of low-dose lopinavir/ritonavir in HIV-infected children |
| 58 |
The 12th Bangkok International Symposium on HIV medicine |
| ปี พ.ศ. 2551 |
| 59 |
Dilated cardiomyopathy in three HIV-infected children after initiation of antiretroviral therapy |
| 60 |
Quality of life among HIV-infected children in Thailand |
| 61 |
Haematological changes after switching from stavudine to zidovudine in HIV-infected children receiving highly active antiretroviral therapy |
| 62 |
Lessons from a multicentre paediatric HIV trial |
| ปี พ.ศ. 2550 |
| 63 |
Hospitalization and mortality among HIV-infected children after receiving highly active antiretroviral therapy |
| 64 |
Response to measles, mumps, and rubella revaccination in HIV-infected children with immune recovery after highly active antiretroviral therapy |
| 65 |
Lipodystrophy and metabolic changes in HIV-infected children on non-nucleoside reverse transcriptase inhibitor-based antiretroviral therapy |
| 66 |
Japanese encephalitis vaccination in HIV-infected children with immune recovery after highly active antiretroviral therapy |
| 67 |
Sustained immunologic and virologic efficacy after four years of highly active antiretroviral therapy in human immunodeficiency virus infected children in Thailand |
| ปี พ.ศ. 2549 |
| 68 |
Prevalence of protective antibody against hepatitis B virus in HIV-infected children with immune recovery after highly active antiretroviral therapy |
| 69 |
Immune reconstitution syndrome after highly active antiretroviral therapy in human immunodeficiency virus-infected Thai children |
| 70 |
Prevalence of protective antibody against measles in HIV-infected children with immune recovery after highly active antiretroviral therapy |
| 71 |
Immune reconstitution syndrome from nontuberculous mycobacterial infection after initiation of antiretroviral therapy in children with HIV infection |
| 72 |
Disclosure of HIV/AIDS diagnosis to HIV-infected children in Thailand |
| ปี พ.ศ. 2548 |
| 73 |
Efficacy of highly active antiretroviral therapy in HIV-infected children participating in Thailand's National Access to Antiretroviral Program |
| 74 |
Growth, developmental, and behavioral outcomes of HIV-affected preschool children in Thailand |
| 75 |
Immune reconstitution syndrome due to bacillus Calmette-Gu?rin after initiation of antiretroviral therapy in children with HIV infection |
| 76 |
A mediastinal mass resembling lymphoma: An unusual manifestation of probable case of invasive zygomycosis in an immunocompetent child |
| 77 |
การศึกษาการตอบสนองต่อการรักษาทั้งในด้านคลินิก ปริมาณไวรัสและระดับ
ภูมิคุ้มกันในผู้ป่วยเด็กโรคเอดส์ที่ได้รับยาต้านไวรัสสูตร 3 ชนิด |
| ปี พ.ศ. 2547 |
| 78 |
Impact of fluconazole prophylaxis on cortisol levels in critically ill surgical patients |
| ปี พ.ศ. 2546 |
| 79 |
Epidemiologic, clinical and laboratory features of scrub typhus in thirty Thai children |
| 80 |
Epidemiology of invasive meningococcal disease in 13 government hospitals in Thailand, 1994-1999 |
| 81 |
An in-house HIV DNA PCR assay for early diagnosis of HIV infection in children in Thailand |
| ปี พ.ศ. ไม่ระบุ |
| 82 |
Antibody response to hepatitis B re-vaccination in HIV-infected children with immune recovery on highly active antiretroviral therapy |
| 83 |
Prevalence of protective level of hepatitis B antibody 3 years after revaccination in HIV-infected children on antiretroviral therapy |
| 84 |
Corrigendum to " The immunogenicity and safety of pneumococcal conjugate vaccine in human immunodeficiency virus-infected Thai children" [Vaccine 29 (2011) 5886-5891] |
